The most reported examples for epigenetic intratumoral heterogeneity are those describing melanoma subpopulations bearing RASSF1A, CDKN2A, DAPK, MGMT, and RB1 genes with hypermethylated promoters [55,56] or melanoma subpopulations with heterogeneous expression of melanoma-associated antigen A3 (MAGE-A3) as a consequence of differential methylation of the MAGE-A3 promoter [56]. The gene discussed is CDKN2A; the disease is melanoma.